Moore Capital Management LP Invests $8.57 Million in Nutrien Ltd. $NTR

Key Points

• Moore Capital Management initiated an $8.57 million position in Nutrien, purchasing 136,106 shares during the second quarter. Institutional investors and hedge funds collectively own 63.1% of the company.
• Nutrien reported quarterly revenue of $10.81 billion, up 3.6% year over year, but earnings of $2.61 per share fell short of the $2.70 consensus estimate. The company declared a quarterly dividend of $0.55 per share, representing a 3.0% annualized yield.
• Analysts maintain a generally positive outlook, with 17 Buy ratings, three Holds and one Sell, producing a “Moderate Buy” consensus and an average price target of $81.58 versus the stock’s recent $73.64 price.

Moore Capital Management LP bought a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 136,106 shares of the company's stock, valued at approximately $8,568,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NTR. Guggenheim Capital LLC lifted its position in shares of Nutrien by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company's stock worth $409,000 after buying an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC grew its position in shares of Nutrien by 1.8% in the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company's stock valued at $557,000 after buying an additional 164 shares during the last quarter. Banque Cantonale Vaudoise raised its stake in Nutrien by 15.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company's stock worth $90,000 after acquiring an additional 164 shares in the last quarter. Gould Asset Management LLC CA raised its stake in Nutrien by 4.4% during the 1st quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company's stock worth $297,000 after acquiring an additional 165 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Nutrien by 21.8% in the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company's stock valued at $61,000 after acquiring an additional 176 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Stock Performance

NYSE NTR opened at $73.64 on Monday. The firm has a market cap of $35.23 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.78 and a beta of 0.61. Nutrien Ltd. has a 52-week low of $53.03 and a 52-week high of $85.36. The business's 50-day moving average price is $67.33 and its 200 day moving average price is $70.57. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The company had revenue of $10.81 billion for the quarter, compared to analysts' expectations of $10.44 billion. During the same period in the prior year, the company earned $2.65 earnings per share. The firm's revenue was up 3.6% on a year-over-year basis. On average, equities research analysts expect that Nutrien Ltd. will post 4.71 earnings per share for the current year.

Nutrien Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be issued a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. Nutrien's dividend payout ratio (DPR) is currently 44.53%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on NTR shares. Oppenheimer reduced their target price on Nutrien from $82.00 to $80.00 and set an "outperform" rating for the company in a report on Thursday, July 23rd. Berenberg Bank set a $65.00 price target on Nutrien and gave the stock a "hold" rating in a research report on Wednesday, June 10th. TD Securities reiterated a "buy" rating on shares of Nutrien in a research note on Wednesday, May 6th. Raymond James Financial raised Nutrien from a "market perform" rating to an "outperform" rating and increased their price objective for the company from $74.00 to $90.00 in a report on Tuesday, May 5th. Finally, UBS Group lowered their target price on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating on the stock in a research report on Monday, May 11th. Seventeen research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $81.58.

Nutrien News Roundup

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.